participant must either be aed therapy na?ve or on an aed excluding benzodiazepine for 1-week or less child may be on a stable dose of psychostimulants at the time of enrollment but no change in medication dose or schedule in 3 month prior to study enrollment with no anticipate dose change during the 6 month of the study if participant be take psychostimulants at the time of study entry they should plan on continue them for the 6 month duration of the study protocol include the 3-month and 6-month cognitive and behavioral testing time point 